naltrexone and oxidopamine

naltrexone has been researched along with oxidopamine in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19902 (14.29)18.7374
1990's6 (42.86)18.2507
2000's4 (28.57)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraban, JM; Bhat, RV; Cole, AJ; Worley, PF1
Ceresoli, G; Groppetti, A; Mandelli, V; Parenti, M1
Di Chiara, G; Morelli, M1
Cavicchini, E; Ferri, S; Murari, G; Romualdi, P; Speroni, E1
Lendvai, B; Sándor, A; Sándor, NT1
Kameyama, T; Toyoshi, T; Ukai, M1
Pruett, SB; Wu, WJ1
Aston-Jones, G; Delfs, JM; Druhan, J; Zhu, Y1
Hyytiä, P; Kiianmaa, K; Koistinen, M; Tuomainen, P1
Benabid, AL; Berger, F; Buggia, V; Gilbert, F; Lévesque, D; Sgambato-Faure, V1
Aburada, M; Kase, Y; Murata, M; Omiya, Y; Suzuki, Y; Takeda, S; Yuzurihara, M1
Mabrouk, OS; Marti, M; Morari, M; Salvadori, S1
Booth, FW; Brown, JD; Kovarik, MC; Miller, DK; Ruegsegger, GN1
Ambriz-Tututi, M; Drucker-Colín, R; Gómez-Paz, A; Milán-Aldaco, D; Palomero-Rivero, M1

Other Studies

14 other study(ies) available for naltrexone and oxidopamine

ArticleYear
Activation of the zinc finger encoding gene krox-20 in adult rat brain: comparison with zif268.
    Brain research. Molecular brain research, 1992, Volume: 13, Issue:3

    Topics: Animals; Apomorphine; Benzazepines; Brain; DNA-Binding Proteins; Early Growth Response Protein 1; Early Growth Response Protein 2; Electroshock; Haloperidol; Immediate-Early Proteins; Male; Morphine; Naltrexone; Nucleic Acid Hybridization; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Seizures; Substance Withdrawal Syndrome; Transcription Factors; Transcription, Genetic; Zinc Fingers

1992
Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:3

    Topics: Adenylyl Cyclases; Animals; Apomorphine; Corpus Striatum; Drug Interactions; Hydroxydopamines; Levodopa; Male; Morphine; Naltrexone; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Opioid

1990
Non-dopaminergic mechanisms in the turning behavior evoked by intranigral opiates.
    Brain research, 1985, Aug-26, Volume: 341, Issue:2

    Topics: Animals; Dynorphins; Enkephalins; Hydroxydopamines; Male; Medial Forebrain Bundle; Morphine; Movement; Naltrexone; Neural Pathways; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra

1985
Possible mediation of catecholaminergic pathways in the antinociceptive effect of an extract of Cannabis sativa L.
    Psychopharmacology, 1986, Volume: 89, Issue:2

    Topics: Analgesics; Animals; Benzomorphans; Cannabis; Dose-Response Relationship, Drug; Enkephalin, Leucine; Haplorhini; Hydroxydopamines; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Oxidopamine; Plant Extracts; Rats; Rats, Inbred Strains

1986
Influence of selective opiate antagonists on striatal acetylcholine and dopamine release.
    Acta physiologica Hungarica, 1993, Volume: 81, Issue:1

    Topics: Acetylcholine; Animals; Corpus Striatum; Dopamine; Electric Stimulation; In Vitro Techniques; Male; Naloxone; Naltrexone; Narcotic Antagonists; Oxidopamine; Rats; Rats, Wistar

1993
Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice.
    European journal of pharmacology, 1995, Dec-29, Volume: 294, Issue:2-3

    Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Mice; Naltrexone; Oxidopamine; Peptide Fragments; Receptors, Opioid

1995
Suppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Animals; Azides; Benzodiazepines; Carbolines; Catecholamines; Corticosterone; Diazepam; Disease Models, Animal; Female; GABA-A Receptor Agonists; Glucocorticoids; Immunity, Cellular; Immunity, Innate; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mifepristone; Nadolol; Naltrexone; Neurosecretory Systems; Oxidopamine; Phentolamine; Picrotoxin; Propranolol; Receptors, GABA-A; Spleen; Sympathetic Nervous System

1996
The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal.
    Annals of the New York Academy of Sciences, 1999, Jun-29, Volume: 877

    Topics: Amygdala; Animals; Axonal Transport; Caudate Nucleus; Male; Microinjections; Morphine Dependence; Naloxone; Naltrexone; Neurons; Norepinephrine; Oxidopamine; Propranolol; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Thalamus; Tyrosine 3-Monooxygenase

1999
Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats.
    Alcoholism, clinical and experimental research, 2001, Volume: 25, Issue:11

    Topics: Animals; Brain Chemistry; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Ethanol; Male; Naltrexone; Narcotic Antagonists; Norepinephrine; Nucleus Accumbens; Oxidopamine; Rats; Self Administration; Serotonin; Sympatholytics

2001
Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.
    Journal of neuropathology and experimental neurology, 2005, Volume: 64, Issue:11

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic Agents; AIDS-Related Complex; Amphetamine; Analgesics, Non-Narcotic; Animals; Antiparkinson Agents; Behavior, Animal; Carrier Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Drug Interactions; Dynorphins; Dyskinesia, Drug-Induced; Functional Laterality; Homer Scaffolding Proteins; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oxidopamine; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation

2005
Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice.
    Journal of pharmacological sciences, 2005, Volume: 99, Issue:4

    Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Chinese Herbal; Glycyrrhiza; Male; Medicine, Kampo; Methysergide; Mice; Naltrexone; Narcotic Antagonists; Oxidopamine; Paeonia; Pain Measurement; Pain Threshold; Piperazines; Serotonin Antagonists; Sympatholytics; Tropanes; Yohimbine

2005
The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway.
    Neuroscience, 2009, Dec-01, Volume: 164, Issue:2

    Topics: Amino Acids; Animals; Antiparkinson Agents; Benzimidazoles; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; Glutamic Acid; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Neural Pathways; Oligopeptides; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substantia Nigra; Thalamus

2009
Mu-opioid receptor inhibition decreases voluntary wheel running in a dopamine-dependent manner in rats bred for high voluntary running.
    Neuroscience, 2016, Dec-17, Volume: 339

    Topics: Animals; Cells, Cultured; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Feeding Behavior; Female; Injections, Intraperitoneal; Motivation; Motor Activity; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Oxidopamine; Rats; Receptors, Opioid, mu; RNA, Messenger; Running; Sedentary Behavior; Species Specificity; Volition

2016
Intrastriatal Chromospheres' Transplant Reduces Nociception in Hemiparkinsonian Rats.
    Neuroscience, 2018, 09-01, Volume: 387

    Topics: Animals; Cells, Cultured; Male; Microinjections; Naltrexone; Nociception; Oxidopamine; Pain Measurement; Parkinsonian Disorders; Rats; Substantia Nigra; Sulpiride

2018